# Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Article · Domenica Rubino, Niclas Abrahamsson, Melanie Jane Davies, Dan Hesse, Frank L. Greenway, Camilla Jensen, Ildiko Lingvay, Ofri Mosenzon, Julio Rosenstock, Miguel A. Rubio, Gottfried Rudofsky, Sayeh Tadayon, Thomas A. Wadden, Dror Dicker, STEP 4 Investigators, M. Friberg, Anders Mikael Sjödin, Gabriella Segal, Muhammad Sabbah, Yael Sofer, Victor Vishlitzky, Eelco W. Meesters, Mirelle Serlie, Arianne C. van Bon, Helena Cardoso and 63 more

- Archive id: doi:10.1001/jama.2021.3224
- Published: 2021-03-23
- Venue: JAMA
- DOI: https://doi.org/10.1001/jama.2021.3224
- PMID: 33755728
- Citations: 1,443
- Source URL: https://doi.org/10.1001/jama.2021.3224
- PDF: https://jamanetwork.com/journals/jama/articlepdf/2777886/jama_rubino_2021_oi_210023_1618250221.55359.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.